MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
Mettler-Toledo International EV - Enterprise Value 2011-2026 | MTD
Annual EV - Enterprise Value Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.1 B | 33.2 B | 29.1 B | 37.3 B | 37.1 B | 30.3 B | 21.2 B | 17.8 B | 19.3 B | 12.8 B | 10 B | 9.99 B | 8.58 B | 7.76 B | 6.8 B | 4.8 B | 3.46 B | 3.48 B | -81.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 37.3 B | -81.2 M | 17.1 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 201.02 | -1.01 % | $ 22.3 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 88.17 | -0.43 % | $ 4.12 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 3.93 | -8.39 % | $ 5.23 M | USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 18.54 | -0.75 % | $ 571 M | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 20.56 | -0.68 % | $ 596 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.65 | 3.12 % | $ 7.3 M | USA |
 |
Illumina
ILMN
|
23.8 B | $ 164.39 | 2.12 % | $ 25.5 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
15.2 B | $ 129.45 | -1.65 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 22.98 | 0.04 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
16.5 B | $ 146.18 | - | $ 11.5 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 11.09 | -0.54 % | $ 1.42 B | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
654 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
432 M | $ 18.35 | -2.34 % | $ 411 M | USA |
 |
Natera
NTRA
|
30.1 B | $ 214.4 | 1.1 % | $ 29.3 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 103.97 | -0.53 % | $ 7.02 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 189.74 | 1.19 % | $ 9.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.37 | 4.2 % | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 467.9 | 0.12 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.29 | -0.92 % | $ 397 M | USA |
 |
Personalis
PSNL
|
380 M | $ 9.8 | 2.19 % | $ 875 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.83 | 1.4 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
376 M | $ 7.28 | 1.35 % | $ 304 M | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 79.83 | 4.81 % | $ 4.77 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.03 | -1.22 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 263.98 | -0.82 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 469.74 | 0.19 % | $ 177 B | USA |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 0.64 | -1.51 % | $ 230 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.13 | 0.33 % | $ 1.98 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |